Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bakris

Showing results (81-90 of 991) with videos related to

Pageof 100
Sort By:
Hospital Practice (1995)|May 1, 1998
Angiotensin II receptor blockers in hypertension and renal diseaseG L Bakris
Postgraduate Medicine|May 27, 2003
The evolution of treatment guidelines for diabetic nephropathy. Strategies integrate JNC VI, more recent protocolsGeorge L Bakris
Journal of Clinical Hypertension (Greenwich, Conn.)|June 2, 2007
ACE inhibitors and ARBs: are they better than other agents to slow nephropathy progression?George L Bakris
Journal of the American Society of Hypertension : JASH|April 23, 2010
Is blockade of the renin-angiotensin system appropriate for all patients with diabetes?George L Bakris
Journal of Managed Care Pharmacy : JMCP|July 4, 2007
Current perspectives on hypertension and metabolic syndromeGeorge L Bakris
Kidney International|July 29, 2010
Dual RAAS blockade is desirable in kidney disease: conGeorge L Bakris
American Journal of Hypertension|April 1, 1993
Hypertension in diabetic patients. An overview of interventional studies to preserve renal functionG L Bakris
Annals of Internal Medicine|April 15, 1993
Angiotensin-converting enzyme inhibitors and progression of diabetic nephropathyG L Bakris
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 3, 2019
Major Advancements in Slowing Diabetic Kidney Disease Progression: Focus on SGLT2 InhibitorsGeorge L Bakris
Journal of Clinical Hypertension (Greenwich, Conn.)|June 21, 2001
Target Organ Damage in HypertensionUnini Odama, George Bakris
Pageof 100

Showing results (81-90 of 991) with videos related to

Sort By:
Pageof 100
Hospital Practice (1995)|May 1, 1998
Angiotensin II receptor blockers in hypertension and renal diseaseG L Bakris
Postgraduate Medicine|May 27, 2003
The evolution of treatment guidelines for diabetic nephropathy. Strategies integrate JNC VI, more recent protocolsGeorge L Bakris
Journal of Clinical Hypertension (Greenwich, Conn.)|June 2, 2007
ACE inhibitors and ARBs: are they better than other agents to slow nephropathy progression?George L Bakris
Journal of the American Society of Hypertension : JASH|April 23, 2010
Is blockade of the renin-angiotensin system appropriate for all patients with diabetes?George L Bakris
Journal of Managed Care Pharmacy : JMCP|July 4, 2007
Current perspectives on hypertension and metabolic syndromeGeorge L Bakris
Kidney International|July 29, 2010
Dual RAAS blockade is desirable in kidney disease: conGeorge L Bakris
American Journal of Hypertension|April 1, 1993
Hypertension in diabetic patients. An overview of interventional studies to preserve renal functionG L Bakris
Annals of Internal Medicine|April 15, 1993
Angiotensin-converting enzyme inhibitors and progression of diabetic nephropathyG L Bakris
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 3, 2019
Major Advancements in Slowing Diabetic Kidney Disease Progression: Focus on SGLT2 InhibitorsGeorge L Bakris
Journal of Clinical Hypertension (Greenwich, Conn.)|June 21, 2001
Target Organ Damage in HypertensionUnini Odama, George Bakris
Pageof 100